162 related articles for article (PubMed ID: 21206026)
1. Crystallization and preliminary X-ray analysis of the vWA domain of human anthrax toxin receptor 1.
Cai C; Zhao Y; Tong X; Fu S; Li Y; Wu Y; Li X; Lou Z
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Jan; 67(Pt 1):64-7. PubMed ID: 21206026
[TBL] [Abstract][Full Text] [Related]
2. The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.
Fu S; Tong X; Cai C; Zhao Y; Wu Y; Li Y; Xu J; Zhang XC; Xu L; Chen W; Rao Z
PLoS One; 2010 Jun; 5(6):e11203. PubMed ID: 20585457
[TBL] [Abstract][Full Text] [Related]
3. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
Scobie HM; Rainey GJ; Bradley KA; Young JA
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348
[TBL] [Abstract][Full Text] [Related]
4. The receptors that mediate the direct lethality of anthrax toxin.
Liu S; Zhang Y; Hoover B; Leppla SH
Toxins (Basel); 2012 Dec; 5(1):1-8. PubMed ID: 23271637
[TBL] [Abstract][Full Text] [Related]
5. Expression and purification of functional human anthrax toxin receptor (ATR/TEM8) binding domain from Escherichia coli.
Ding Z; Bradley KA; Amin Arnaout M; Xiong JP
Protein Expr Purif; 2006 Sep; 49(1):121-8. PubMed ID: 16798009
[TBL] [Abstract][Full Text] [Related]
6. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.
Chen KH; Liu S; Bankston LA; Liddington RC; Leppla SH
J Biol Chem; 2007 Mar; 282(13):9834-9845. PubMed ID: 17251181
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor.
Lacy DB; Wigelsworth DJ; Scobie HM; Young JA; Collier RJ
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6367-72. PubMed ID: 15079089
[TBL] [Abstract][Full Text] [Related]
8. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.
Liu S; Crown D; Miller-Randolph S; Moayeri M; Wang H; Hu H; Morley T; Leppla SH
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12424-9. PubMed ID: 19617532
[TBL] [Abstract][Full Text] [Related]
9. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.
Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ
J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490
[TBL] [Abstract][Full Text] [Related]
10. Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors.
Cai C; Che J; Xu L; Guo Q; Kong Y; Fu L; Xu J; Cheng Y; Chen W
PLoS One; 2011; 6(6):e20646. PubMed ID: 21674060
[TBL] [Abstract][Full Text] [Related]
11. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of a complex between anthrax toxin and its host cell receptor.
Santelli E; Bankston LA; Leppla SH; Liddington RC
Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
[TBL] [Abstract][Full Text] [Related]
13. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.
Martchenko M; Jeong SY; Cohen SN
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15583-8. PubMed ID: 20713715
[TBL] [Abstract][Full Text] [Related]
14. Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.
Mamillapalli S; Miyagi M; Bann JG
Protein Sci; 2017 Feb; 26(2):355-364. PubMed ID: 27874231
[TBL] [Abstract][Full Text] [Related]
15. Receptor-specific requirements for anthrax toxin delivery into cells.
Rainey GJ; Wigelsworth DJ; Ryan PL; Scobie HM; Collier RJ; Young JA
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13278-83. PubMed ID: 16141341
[TBL] [Abstract][Full Text] [Related]
16. Interactions between anthrax toxin receptors and protective antigen.
Scobie HM; Young JA
Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
Stiles L; Nelson DJ
J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
[TBL] [Abstract][Full Text] [Related]
18. Disulfide bonds in the ectodomain of anthrax toxin receptor 2 are required for the receptor-bound protective-antigen pore to function.
Sun J; Collier RJ
PLoS One; 2010 May; 5(5):e10553. PubMed ID: 20479891
[TBL] [Abstract][Full Text] [Related]
19. Targeted silencing of anthrax toxin receptors protects against anthrax toxins.
Arévalo MT; Navarro A; Arico CD; Li J; Alkhatib O; Chen S; Diaz-Arévalo D; Zeng M
J Biol Chem; 2014 May; 289(22):15730-8. PubMed ID: 24742682
[TBL] [Abstract][Full Text] [Related]
20. Changing the receptor specificity of anthrax toxin.
Mechaly A; McCluskey AJ; Collier RJ
mBio; 2012; 3(3):. PubMed ID: 22550037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
